FRDTX
Price
$95.73
Change
-$0.00 (-0.00%)
Updated
Nov 4 closing price
VFINX
Price
$527.63
Change
-$0.00 (-0.00%)
Updated
Nov 4 closing price
Ad is loading...

FRDTX vs VFINX

Header iconFRDTX vs VFINX Comparison
Open Charts FRDTX vs VFINXBanner chart's image
Franklin Rising Dividends C
Price$95.73
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard 500 Index Investor
Price$527.63
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
FRDTX vs VFINX Comparison Chart
Loading...
VS
FRDTX vs. VFINX commentary
Nov 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FRDTX is a Buy and VFINX is a Buy.

FUNDAMENTALS
Fundamentals
VFINX has more cash in the bank: 1.28T vs. FRDTX (28.2B). VFINX pays higher dividends than FRDTX: VFINX (1.24) vs FRDTX (0.20). FRDTX was incepted earlier than VFINX: FRDTX (30 years) vs VFINX (48 years). VFINX is a more actively managed with annual turnover of: 2.00 vs. FRDTX (1.88). VFINX has a lower initial minimum investment than FRDTX: VFINX (0) vs FRDTX (1000). VFINX annual gain was more profitable for investors over the last year : 31.14 vs. FRDTX (15.02). VFINX return over 5 years is better than : 85.76 vs. FRDTX (44.29).
FRDTXVFINXFRDTX / VFINX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence30 years48 years-
Gain YTD10.81419.94354%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets28.2B1.28T2%
Annual Yield % from dividends0.201.2416%
Returns for 1 year15.0231.1448%
Returns for 3 years-1.3921.64-6%
Returns for 5 years44.2985.7652%
Returns for 10 years90.55182.7150%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
THAR2.930.24
+8.92%
Tharimmune Inc.
IRMD49.190.89
+1.84%
iRadimed Corp
STN82.390.90
+1.10%
Stantec
SNEX91.340.59
+0.65%
StoneX Group
IVVD0.90-0.01
-1.49%
Invivyd